This inventor holds 2 USPTO granted patents. Top assignees: Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd, Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Baolin Lai: Innovator in Breast Cancer Treatment
Introduction
Baolin Lai is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of breast cancer. His innovative approach has the potential to change the landscape of cancer treatment.
Latest Patents
Baolin Lai holds a patent for the use of mitoxantrone preparation in the preparation of a drug for diagnosing and treating breast cancer. This patent outlines the use of mitoxantrone and/or a pharmaceutically acceptable salt in the preparation of a lymphatic tracer for diseases associated with breast resection. The preparation has shown no local or systemic toxic and side effects after local injection, indicating good tolerance, effectiveness, and safety. This innovation provides a new treatment idea for thoroughly curing breast cancer in patients.
Career Highlights
Throughout his career, Baolin Lai has worked with notable companies such as Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd and Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Baolin Lai has collaborated with esteemed colleagues, including Jun Liu and Xun Li. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Baolin Lai's contributions to breast cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work exemplifies the importance of innovation in the medical field and highlights the potential for new treatments to emerge from dedicated research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile